Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![plainyogurt21 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::791473106007097345.png) Adu Subramanian [@plainyogurt21](/creator/twitter/plainyogurt21) on x 4178 followers
Created: 2025-07-17 20:20:32 UTC

I don't think this expands the market: if you have the gene, you will have the disease. but it will pull forward demand away from long term competition IF QURE shows a strong benefit (5 years slowing). I would be cautious about the eligible patient range and FDA label for it. If it's not on label (becuase not in the trial), then no way insurance covers it


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945941710074532079/c:line.svg)

**Related Topics**
[insurance](/topic/insurance)

[Post Link](https://x.com/plainyogurt21/status/1945941710074532079)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

plainyogurt21 Avatar Adu Subramanian @plainyogurt21 on x 4178 followers Created: 2025-07-17 20:20:32 UTC

I don't think this expands the market: if you have the gene, you will have the disease. but it will pull forward demand away from long term competition IF QURE shows a strong benefit (5 years slowing). I would be cautious about the eligible patient range and FDA label for it. If it's not on label (becuase not in the trial), then no way insurance covers it

XXX engagements

Engagements Line Chart

Related Topics insurance

Post Link

post/tweet::1945941710074532079
/post/tweet::1945941710074532079